Disparities in opioid treatment access remain for women, Black and Hispanic people

ROCHESTER, Minn. — Buprenorphine is a prescription approved by the Food and Drug Administration (FDA) that effectively treats opioid dependence or addiction. But women, as well as Black and Hispanic populations, do not have equal access to this potentially lifesaving medication, new Mayo Clinic research finds. The study published Friday, June 3, in JAMA Network Open. The research team used the OptumLabs Data Warehouse to examine 3,110 filled prescriptions of buprenorphine from 72,055 emergency department visits across the…
Source: Mayo Clinic Research News - Category: Research Source Type: news